These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 954007

  • 1. Chemistry and structure-activity studies of the nitrosoureas.
    Montgomery JA.
    Cancer Treat Rep; 1976 Jun; 60(6):651-64. PubMed ID: 954007
    [Abstract] [Full Text] [Related]

  • 2. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM.
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [Abstract] [Full Text] [Related]

  • 3. Biologic activity of MCNU: a new antitumor agent.
    Sekido S, Ninomiya K, Iwasaki M.
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ, Wilson GL, Mossman BT, Angelino N, Kanter PM, Korytnyk W.
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [Abstract] [Full Text] [Related]

  • 5. Structure-activity relationships: nitrosoureas.
    Johnston TP.
    Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
    Montgomery JA, McCaleb GS, Johnston TP, Mayo JG, Laster WR.
    J Med Chem; 1977 Feb; 20(2):291-5. PubMed ID: 836501
    [Abstract] [Full Text] [Related]

  • 7. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
    Papageorgiou A, Lialiaris T, Stergiou E, Stergiou I, Tsigris C, Kourti A, Geromichalos G, Stravoravdi P, Trafalis D, Athanassiou AE, Pitsas A, Camoutsis Ch.
    J BUON; 2008 Feb; 13(2):235-9. PubMed ID: 18555471
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S, Tashiro T, Ogawa M.
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [Abstract] [Full Text] [Related]

  • 9. Cytostatic action of two nitrosoureas derived from cysteamine.
    Bourut C, Chenu E, Godenèche D, Madelmont JC, Maral R, Mathé G, Meyniel G.
    Br J Pharmacol; 1986 Nov; 89(3):539-46. PubMed ID: 3801787
    [Abstract] [Full Text] [Related]

  • 10. [Synthesis of new nitrosoureas].
    Papadaki-Valiraki A, Siatra-Papastaikoudi T, Skaltsounis AL, Roussakis C.
    Ann Pharm Fr; 1989 Nov; 47(6):394-401. PubMed ID: 2488253
    [Abstract] [Full Text] [Related]

  • 11. A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureas.
    Tsujihara K, Ozeki M, Morikawa T, Kawamori M, Akaike Y, Arai Y.
    J Med Chem; 1982 Apr; 25(4):441-6. PubMed ID: 7069723
    [Abstract] [Full Text] [Related]

  • 12. Comparison of mutagenicity, antitumor activity, and chemical properties of selected nitrosoureas and nitrosoamides.
    Brundrett RB, Colvin M, White EH, McKee J, Hartman PE, Brown DL.
    Cancer Res; 1979 Apr; 39(4):1328-33. PubMed ID: 421216
    [Abstract] [Full Text] [Related]

  • 13. Spin labeled amino acid nitrosourea derivatives--synthesis and antitumour activity.
    Zheleva A, Raikov Z, Ilarionova M, Todorov D.
    Pharmazie; 1995 Jan; 50(1):25-6. PubMed ID: 7886121
    [Abstract] [Full Text] [Related]

  • 14. New cysteamine (2-chloroethyl)nitrosoureas. Synthesis and preliminary antitumor results.
    Madelmont JC, Godeneche D, Parry D, Duprat J, Chabard JL, Plagne R, Mathe G, Meyniel G.
    J Med Chem; 1985 Sep; 28(9):1346-50. PubMed ID: 4032435
    [Abstract] [Full Text] [Related]

  • 15. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
    Carter SK, Schabel FM, Broder LE, Johnston TP.
    Adv Cancer Res; 1972 Sep; 16():273-332. PubMed ID: 4563045
    [No Abstract] [Full Text] [Related]

  • 16. Synergistic antileukemic activity of combinations of two nitrosoureas.
    Wheeler GP, Schabel FM, Trader MW.
    Cancer Treat Rep; 1981 Sep; 65(7-8):591-9. PubMed ID: 6454482
    [Abstract] [Full Text] [Related]

  • 17. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.
    Johnston TP, Montgomery JA.
    Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250
    [No Abstract] [Full Text] [Related]

  • 18. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
    Rose WC, Trader MW, Dykes DJ, Laster WR, Schabel FM.
    Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
    [Abstract] [Full Text] [Related]

  • 19. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
    Mori KJ, Jasmin C, Hayat M, MacDonald JS, Mathé G.
    Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
    [No Abstract] [Full Text] [Related]

  • 20. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP, Schein PS.
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.